DK2107055T3 - Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number: DK2107055T3
Authority: DK; Denmark
Prior art keywords: dosmetin; derivatives; preparation; pharmaceutical compositions; compositions containing
Prior art date: 2008-04-01

Application number

DK09290237.8T

Other languages

English (en)

Inventor

Michel Wierzbicki

Marie Francoise Boussard

Patricia Sansilvestri-Morel

Alain Rupin

Jerome Paysant

Francois Lefoulon

Tony Verbeuren

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-01

Filing date

2009-03-31

Publication date

2011-06-27

2009-03-31 Application filed by Servier Lab filed Critical Servier Lab

2011-06-27 Application granted granted Critical

2011-06-27 Publication of DK2107055T3 publication Critical patent/DK2107055T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK09290237.8T 2008-04-01 2009-03-31 Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK2107055T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0801779A FR2929276B1 (fr)	2008-04-01	2008-04-01	Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
DK2107055T3 true DK2107055T3 (da)	2011-06-27

Family

ID=39809617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK09290237.8T DK2107055T3 (da)	2008-04-01	2009-03-31	Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (48)

Country	Link
US (2)	US8138223B2 (da)
EP (1)	EP2107055B1 (da)
JP (1)	JP5047211B2 (da)
KR (1)	KR20120049855A (da)
CN (1)	CN101550124B (da)
AP (1)	AP3024A (da)
AR (2)	AR071120A1 (da)
AT (1)	ATE502024T1 (da)
AU (1)	AU2009201068B2 (da)
BR (1)	BRPI0900983B8 (da)
CA (1)	CA2659947C (da)
CL (1)	CL2009000757A1 (da)
CO (1)	CO6150038A1 (da)
CR (1)	CR10665A (da)
CU (1)	CU23761B7 (da)
CY (1)	CY1111367T1 (da)
DE (1)	DE602009000873D1 (da)
DK (1)	DK2107055T3 (da)
EA (1)	EA015424B1 (da)
EC (1)	ECSP099216A (da)
ES (1)	ES2363196T3 (da)
FR (1)	FR2929276B1 (da)
GE (1)	GEP20115342B (da)
GT (1)	GT200900062A (da)
HK (1)	HK1136291A1 (da)
HN (1)	HN2009000566A (da)
HR (1)	HRP20110361T1 (da)
IL (1)	IL197638A (da)
JO (1)	JO2673B1 (da)
MA (1)	MA31413B1 (da)
ME (1)	ME00680B (da)
MX (1)	MX2009003383A (da)
MY (1)	MY144726A (da)
NI (1)	NI200900042A (da)
NZ (1)	NZ575902A (da)
PE (1)	PE20091692A1 (da)
PL (1)	PL2107055T3 (da)
PT (1)	PT2107055E (da)
RS (1)	RS51661B (da)
SA (1)	SA109300201B1 (da)
SG (1)	SG155849A1 (da)
SI (1)	SI2107055T1 (da)
SV (1)	SV2009003199A (da)
TW (1)	TWI385178B (da)
UA (1)	UA98623C2 (da)
UY (1)	UY31712A1 (da)
WO (1)	WO2009133269A1 (da)
ZA (1)	ZA200901947B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2002835A1 (en)	2007-06-04	2008-12-17	GenKyo Tex	Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166009A1 (en)	2008-09-23	2010-03-24	Genkyo Tex Sa	Pyrazolo pyridine derivatives as nadph oxidase inhibitors
EP2166010A1 (en)	2008-09-23	2010-03-24	Genkyo Tex Sa	Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2165707A1 (en)	2008-09-23	2010-03-24	Genkyo Tex Sa	Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2305679A1 (en)	2009-09-28	2011-04-06	GenKyoTex SA	Pyrazoline dione derivatives as nadph oxidase inhibitors
FR3002543A1 (fr)	2013-02-28	2014-08-29	Servier Lab	Procede de synthese enzymatique de flavonoides, et application a la synthese de derives de diosmetine
CN106031723A (zh) *	2015-09-29	2016-10-19	西南大学	香叶木素的抗炎活性及其制剂应用
CN106822087A (zh) *	2017-01-12	2017-06-13	西南大学	香叶木素在制备治疗ⅱ型糖尿病的药物中的应用
EP3619209A1 (en) *	2017-05-04	2020-03-11	Glenmark Pharmaceuticals S.A.	Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitors
KR102717665B1 (ko) *	2017-07-19	2024-10-14	프리머스 파머수티컬즈, 인크.	자가면역 미세혈관 장애의 치료 방법
CN109280067B (zh) *	2017-07-21	2022-07-05	南京正大天晴制药有限公司	香叶木苷衍生物、其制备方法以及医药用途
JP2021501198A (ja) *	2017-10-27	2021-01-14	トランスフュージョンヘルス，リミティドライアビリティカンパニー	フルオレンの誘導体を用いて造血幹細胞を増殖する組成物および方法
EP3479843A1 (en)	2017-11-01	2019-05-08	GenKyoTex Suisse SA	Use of nox inhibitors for treatment of cancer
CN109394753B (zh) *	2018-12-24	2020-10-02	武汉轻工大学	香叶木素在制备预防和/或治疗高尿酸血症肾病的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2701261B1 (fr) *	1993-02-05	1995-03-31	Adir	Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2726273B1 (fr) *	1994-10-26	1996-12-06	Adir	Nouveaux derives de la diosmetine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2748025B1 (fr) *	1996-04-25	1998-10-30	Adir	Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant
KR100595332B1 (ko) *	1998-03-12	2006-07-03	데이진 가부시키가이샤	벤조푸릴피론 유도체
GB9920912D0 (en) *	1999-09-03	1999-11-10	Indena Spa	Novel derivatives of flavones,xanthones and coumarins
FR2882654B1 (fr) *	2005-03-01	2007-04-27	Servier Lab	Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques

2008
- 2008-04-01 FR FR0801779A patent/FR2929276B1/fr not_active Expired - Fee Related
2009
- 2009-03-12 SG SG200901706-2A patent/SG155849A1/en unknown
- 2009-03-12 PE PE2009000365A patent/PE20091692A1/es active IP Right Grant
- 2009-03-13 UY UY31712A patent/UY31712A1/es active IP Right Grant
- 2009-03-13 MY MYPI20091038A patent/MY144726A/en unknown
- 2009-03-17 AU AU2009201068A patent/AU2009201068B2/en active Active
- 2009-03-17 JO JO2009107A patent/JO2673B1/en active
- 2009-03-17 IL IL197638A patent/IL197638A/en active IP Right Grant
- 2009-03-17 CR CR10665A patent/CR10665A/es unknown
- 2009-03-18 GT GT200900062A patent/GT200900062A/es unknown
- 2009-03-19 ZA ZA2009/01947A patent/ZA200901947B/en unknown
- 2009-03-20 CO CO09029385A patent/CO6150038A1/es active IP Right Grant
- 2009-03-23 AP AP2009004810A patent/AP3024A/xx active
- 2009-03-25 GE GEAP200911185A patent/GEP20115342B/en unknown
- 2009-03-26 CU CU20090048A patent/CU23761B7/es active IP Right Grant
- 2009-03-27 UA UAA200902916A patent/UA98623C2/ru unknown
- 2009-03-27 CN CN2009101324295A patent/CN101550124B/zh active Active
- 2009-03-27 CL CL2009000757A patent/CL2009000757A1/es unknown
- 2009-03-30 EC EC2009009216A patent/ECSP099216A/es unknown
- 2009-03-30 MX MX2009003383A patent/MX2009003383A/es active IP Right Grant
- 2009-03-30 SV SV2009003199A patent/SV2009003199A/es unknown
- 2009-03-30 SA SA109300201A patent/SA109300201B1/ar unknown
- 2009-03-30 MA MA31742A patent/MA31413B1/fr unknown
- 2009-03-30 US US12/383,888 patent/US8138223B2/en active Active
- 2009-03-30 NZ NZ575902A patent/NZ575902A/en unknown
- 2009-03-30 HN HN2009000566A patent/HN2009000566A/es unknown
- 2009-03-31 ME MEP-2009-109A patent/ME00680B/me unknown
- 2009-03-31 EP EP09290237A patent/EP2107055B1/fr active Active
- 2009-03-31 ES ES09290237T patent/ES2363196T3/es active Active
- 2009-03-31 DK DK09290237.8T patent/DK2107055T3/da active
- 2009-03-31 PT PT09290237T patent/PT2107055E/pt unknown
- 2009-03-31 BR BRPI0900983A patent/BRPI0900983B8/pt active IP Right Grant
- 2009-03-31 NI NI200900042A patent/NI200900042A/es unknown
- 2009-03-31 JP JP2009084080A patent/JP5047211B2/ja active Active
- 2009-03-31 PL PL09290237T patent/PL2107055T3/pl unknown
- 2009-03-31 RS RS20110142A patent/RS51661B/en unknown
- 2009-03-31 AR ARP090101138A patent/AR071120A1/es active IP Right Grant
- 2009-03-31 CA CA2659947A patent/CA2659947C/fr active Active
- 2009-03-31 TW TW098110698A patent/TWI385178B/zh not_active IP Right Cessation
- 2009-03-31 AT AT09290237T patent/ATE502024T1/de active
- 2009-03-31 SI SI200930019T patent/SI2107055T1/sl unknown
- 2009-03-31 EA EA200900397A patent/EA015424B1/ru unknown
- 2009-03-31 WO PCT/FR2009/000371 patent/WO2009133269A1/fr active Application Filing
- 2009-03-31 DE DE602009000873T patent/DE602009000873D1/de active Active
2010
- 2010-03-29 HK HK10103244.6A patent/HK1136291A1/xx not_active IP Right Cessation
2011
- 2011-03-22 CY CY20111100344T patent/CY1111367T1/el unknown
- 2011-05-16 HR HR20110361T patent/HRP20110361T1/hr unknown
2012
- 2012-02-14 US US13/372,811 patent/US8404742B2/en active Active
- 2012-04-16 KR KR1020120039373A patent/KR20120049855A/ko not_active Application Discontinuation
2017
- 2017-09-28 AR ARP170102686A patent/AR109739A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
GT200900062A (es)	2011-10-13
JO2673B1 (en)	2012-06-17
JP2009263354A (ja)	2009-11-12
CO6150038A1 (es)	2010-04-20
ATE502024T1 (de)	2011-04-15
RS51661B (en)	2011-10-31
SV2009003199A (es)	2009-10-27
CA2659947A1 (fr)	2009-10-01
AR109739A2 (es)	2019-01-16
UY31712A1 (es)	2009-05-29
TW200944539A (en)	2009-11-01
DE602009000873D1 (de)	2011-04-28
HK1136291A1 (en)	2010-06-25
CU20090048A7 (es)	2011-03-21
CU23761B7 (es)	2012-01-31
KR20120049855A (ko)	2012-05-17
PT2107055E (pt)	2011-05-09
PL2107055T3 (pl)	2011-06-30
CR10665A (es)	2009-05-25
FR2929276B1 (fr)	2010-04-23
MX2009003383A (es)	2009-10-16
SI2107055T1 (sl)	2011-05-31
UA98623C2 (ru)	2012-06-11
IL197638A0 (en)	2009-12-24
NZ575902A (en)	2010-12-24
MA31413B1 (fr)	2010-06-01
TWI385178B (zh)	2013-02-11
BRPI0900983B1 (pt)	2020-01-28
BRPI0900983B8 (pt)	2021-05-25
SA109300201B1 (ar)	2013-04-20
ES2363196T3 (es)	2011-07-26
IL197638A (en)	2014-06-30
EA200900397A1 (ru)	2010-10-29
CN101550124B (zh)	2011-11-30
JP5047211B2 (ja)	2012-10-10
CA2659947C (fr)	2012-05-08
ECSP099216A (es)	2010-03-31
WO2009133269A1 (fr)	2009-11-05
AU2009201068A1 (en)	2009-10-15
ZA200901947B (en)	2010-02-24
SG155849A1 (en)	2009-10-29
HRP20110361T1 (hr)	2011-06-30
CL2009000757A1 (es)	2010-03-26
EA015424B1 (ru)	2011-08-30
GEP20115342B (en)	2011-12-12
EP2107055A1 (fr)	2009-10-07
AP3024A (en)	2014-11-30
MEP10909A (xx)	2011-12-20
CY1111367T1 (el)	2015-08-05
ME00680B (me)	2011-12-20
US20090247621A1 (en)	2009-10-01
BRPI0900983A2 (pt)	2009-11-17
HN2009000566A (es)	2011-07-11
PE20091692A1 (es)	2009-11-07
MY144726A (en)	2011-10-31
US8404742B2 (en)	2013-03-26
US20120208777A1 (en)	2012-08-16
NI200900042A (es)	2010-03-19
FR2929276A1 (fr)	2009-10-02
CN101550124A (zh)	2009-10-07
US8138223B2 (en)	2012-03-20
AP2009004810A0 (en)	2009-04-30
AR071120A1 (es)	2010-05-26
EP2107055B1 (fr)	2011-03-16
AU2009201068B2 (en)	2012-11-22

Publication	Publication Date	Title
DK2107055T3 (da)	2011-06-27	Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK2036892T3 (da)	2010-06-07	1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK3196309T3 (da)	2019-11-25	Thraustochytrider, fedtsyresammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
PL1902706T3 (pl)	2017-04-28	Trwałe w roztworze kompozycje farmaceutyczne tetracyklin, sposób ich otrzymywania i ich zastosowania
DK2044076T3 (da)	2010-02-01	Fremgangsmåde til fremstilling af asenapin og intermediatprodukter, som anvendes i fremgangsmåden
DK2413912T3 (da)	2019-06-17	Farmaceutiske formuleringer, der omfatter nitrocatecholderivater, og metoder til fremstilling deraf
BRPI0919331A2 (pt)	2015-12-29	derivados de pirazolo piridina, composições farmacêuticas e métodos associados
IL211018A (en)	2015-11-30	Inhibitors, processes for making them, medicinal preparations containing them and their use
FI20070569A0 (fi)	2007-07-25	Uusi stabiili tuote ja menetelmä sen valmistamiseksi
DK3156075T3 (da)	2020-11-30	Oligosaccharid og fremgangsmåde til fremstilling deraf
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados
DK2245026T3 (da)	2012-10-15	Spirocycliske heterocycler, lægemiddel indeholdende disse forbindelser, deres anvendelse og fremgangsmåde til deres fremstilling
DK2281822T3 (da)	2013-04-22	Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
DK2205105T3 (da)	2012-10-08	Røgfri, oral tobakssammensætning og fremgangsmåder til fremstilling deraf
BRPI0907228A2 (pt)	2015-07-14	Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
DK1953161T3 (da)	2009-11-30	Nye tricykliske derivater, fremgangsmåde til fremstilling af samme og farmaceutiske sammensætninger indeholdende disse
DK1707564T3 (da)	2008-01-21	Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK2231598T3 (da)	2011-12-05	Nye diazeniumdiolatderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK2320739T3 (da)	2020-02-24	Farmaceutiske sammensætninger og fremgangsmåder til stabilisering af disse
DK2268644T3 (da)	2011-10-10	Tricycliske pyridinderivater, medikamenter indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde til deres fremstilling
DK2987798T3 (da)	2017-11-13	Trehalosederivater og farmaceutiske sammensætninger til behandling af neurodegenerative sygdomme, der indeholder disse
IL220376A (en)	2016-05-31	Polycyclic heterocyclic compounds, process for their preparation, intermediates obtained in said process and pharmaceutical compositions comprising said compounds
DK2094638T3 (da)	2012-11-19	2-aryl-2-fluorpropansyrer og derivater og farmaceutiske sammensætninger, der indeholder dem
DK2147915T3 (da)	2010-12-20	Nye cycloalkylerede benzothiadiazinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1979321T3 (da)	2009-11-02	Nye pyridinylaminoalkylen- og pyridinyloxyalkylen-cyclopropanaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dissse